Find us on:

Research

Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis

Title
Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis
Publication Type
Journal Article
Research Type
Human
Reported as
Case Report/Series/Restrospective Study
Date
January 23, 2019
Authors
E. P. Beltran Monasterio
Institution
Universidade Gama Filho
Link
Abstract

This clinical case demonstrates the benefits of patient treatment with low-dose naltrexone(LDN) used in erythrodermic psoriasis. A patient with a confirmed history of psoriasis by histopathology was treated with 4.5 mg of LDN during six months follow-up after an erythrodermic psoriasis flare-up. The patient showed significant improvement in her flare-upand psoriasis remission after only three months of 4.5 mg of LDN on a daily basis. Low-dose-naltrexone (LDN) has proven to be a great ally in treating erythrodermic psoriasis flare-ups as an alternative treatment with less collateral side effects.